Literature DB >> 7504072

Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope.

P Beauverger1, R Buckland, T F Wild.   

Abstract

We have studied the induction of the cytotoxic T lymphocyte (CTL) response to measles virus (MV) antigens expressed as vaccinia virus (VV) recombinants in a murine model. In C3H mice (H-2k) only the nucleoprotein (NP) induced a CTL response and this was shown to be cross-reactive with the closely related canine distemper virus (CDV). The presentation of this antigen was shown to be Kk-restricted. In BALB/c mice (H-2d), both the haemagglutinin (HA) and the NP induced a strong CTL response, the former being serotype-specific, whereas the latter cross-reacted with CDV. Both responses were found to be Ld-restricted. Based on the prediction for Ld T cell motifs, we tested a number of MV NP-derived nonapeptides for their capacity to sensitize P815 cells (H-2d) for lysis by spleen cells from VV-NP-immunized mice. One of these peptides, comprising amino acids 281 to 289 (Tyr-Pro-Ala-Leu-Gly-Leu-His-Glu-Phe) was as effective as cells expressing the complete NP protein. This motif is conserved in the CDV NP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504072     DOI: 10.1099/0022-1317-74-11-2357

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice.

Authors:  S Dethlefs; N Escriou; M Brahic; S van der Werf; E L Larsson-Sciard
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 2.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  The use of bovine MHC class I allele-specific peptide motifs and proteolytic cleavage specificities for the prediction of potential cytotoxic T lymphocyte epitopes of bovine viral diarrhea virus.

Authors:  N R Hegde; S Srikumaran
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen.

Authors:  A I Cardoso; N Sixt; A Vallier; J Fayolle; R Buckland; T F Wild
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection.

Authors:  C B Stephensen; J Welter; S R Thaker; J Taylor; J Tartaglia; E Paoletti
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Prediction of potential cytotoxic T lymphocyte epitopes of bovine herpesvirus 1 based on allele-specific peptide motifs and proteolytic cleavage specificities.

Authors:  N R Hegde; S Srikumaran
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

7.  Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children.

Authors:  A Jaye; A F Magnusen; A D Sadiq; T Corrah; H C Whittle
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

8.  Specificity of the H-2 L(d)-restricted cytotoxic T-lymphocyte response to the mouse hepatitis virus nucleocapsid protein.

Authors:  C C Bergmann; S A Stohlman
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

9.  Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression.

Authors:  Julien C Marie; Frédéric Saltel; Jean-Michel Escola; Pierre Jurdic; T Fabian Wild; Branka Horvat
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

10.  Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections.

Authors:  B Horvat; P Rivailler; G Varior-Krishnan; A Cardoso; D Gerlier; C Rabourdin-Combe
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.